Research on the Mechanism Affecting Progression of Bronchiectasis
A legfontosabb adatok
- Ki végzi
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Hol
- Guiyang, Wuhan és Yichang (Kína)Mind a 3 helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 150 fő, tervezett
- Kezdés
- 2021. febr. 1.
- Várható befejezés
- 2030. dec. 31.
- A vizsgálat típusa
- Megfigyeléses, 4 csoport
- A vizsgált kezelések
- Pseudomonas aeruginosa colonization infection
- Macrolides
- A regiszteradat frissítve
- 2026. január 5.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with bronchiectasis, a long-term disease where the airways in the lungs are widened. They must cough up phlegm regularly. Researchers will study germs and other substances in phlegm, stool and blood.
- Életkor
- 18 years or older
- Nem
- All sexes
- A betegség stádiuma
- Bronchiectasis confirmed by a high-resolution CT scan (HRCT). Long-term coughing up of phlegm, with the ability to give a phlegm sample at the study visit.
A részvétel fő kizáró okai
- Traction bronchiectasis (widened airways caused by scarring of the lung around them)
- Important clinical information is missing
A regiszter feltételei, szó szerint
Mind a 6 feltétel megnézéseKevesebb
Ki vehet részt
- 18 years or older
- Bronchiectasis confirmed by high-resolution computed tomographic scan(HRCT)
- Chronic expectoration with ability to provide a sputum sample at the study visit
- Provision of written informed consent
Ki nem vehet részt
- Traction bronchiectasis
- Lack of important clinical information
Helyszínek itt: Kína
- Guizhou Provincial People's HospitalGuiyang, KínaContact: Lin Liu, Ph.D., M.D.Résztvevőt keres
- Wuhan Union HospitalWuhan, KínaContact: Xiaorong WangRésztvevőt keres
- Department of Respiratory and Critical Care Medicine, Yichang Central People's HospitalYichang, KínaContact: Xinyu SongRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
Bronchiectasis is a chronic inflammatory respiratory disease defined as the irreversible dilatation of one or more bronchi and is associated with chronic and frequently purulent expectoration, multiple exacerbations and progressive dyspnea. Bronchiectasis has a large heterogeneity. Different patients with bronchiectasis may have different etiology, clinical manifestations, and imaging features. Previous studies showed that there are significant relationship between the airway microbiome and the severity of the disease. For example, patient with airway Pseudomonas aeruginosa colonization has heavier symptoms, heavier severity, poorer quality of life, more acute exacerbations, and worse prognosis. A large number of studies have reported that long-term treatment of low-dose macrolides such as azithromycin or clarithromycin has anti-inflammatory and immunomodulatory effects, which can improve the clinical symptoms and disease progression of various chronic airway diseases, such as diffuse panbronchiolitis, chronic obstructive pulmonary disease, bronchiectasis. Both the 2017 European Respiratory Society guidelines and the 2019 British Thoracic Society Guideline recommend macrolide drugs for the treatment of chronic Pseudomonas aeruginosa colonization bronchiectasis or frequent acute exacerbations bronchiectasis, but the specific mechanism is unknown.This study is based on omics methods (Microbiology and Metabolomics) to deeply explore the composition of airway and gut microbiota in patients with bronchiectasis, the factors affecting the colonization of Pseudomonas aeruginosa and the mechanism of macrolides in the treatment of bronchiectasis.
A teljes eredeti leírásKevesebb
This project is a multicenter clinical study involving patients with bronchiectasis from Wuhan Union Hospital, Guizhou Provincial People's Hospital, and Yichang Central People's Hospital. Patients with bronchiectasis were recruited according to the inclusion and exclusion criteria. Clinical data were collected from these patients (including demographic information, clinical characteristics, pulmonary function, and lung imaging), along with spontaneously expectorated sputum, feces, and peripheral blood, and the patients were followed for 24 months. The microbiome, metabolome, and cytokines in sputum and feces were assessed, as well as cytokines, inflammatory mediators, and metabolites in peripheral blood.
Through the above methods,investigators further understand the mechanism affecting progression of bronchiectasis and some factors that lead to the colonization of Pseudomonas aeruginosa, as well as mechanisms of macrolides in the treatment of bronchiectasis.
A vizsgálat 4 csoportja
- Pseudomonas aeruginosa colonization group
Colonization of Pseudomonas aeruginosa in the airways of patients with bronchiectasis
Kezelés: Pseudomonas aeruginosa colonization infection
- Non-Pseudomonas aeruginosa colonization group
No colonization of Pseudomonas aeruginosa in the airways of patients with bronchiectasis
Kezelés: Pseudomonas aeruginosa colonization infection
- Before treatment with macrolides
Before treatment with macrolides in patients with bronchiectasis
Kezelés: Macrolides
- After treatment with macrolides
After 6 months of treatment with macrolides for patients with bronchiectasis
Kezelés: Macrolides
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Research on the Mechanism Affecting Progression of Bronchiectasis Based on Omics Method
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. január 5.